Clinical Trials Directory

Trials / Conditions / Bronchoalveolar Cell Lung Cancer

Bronchoalveolar Cell Lung Cancer

13 registered clinical trials studyying Bronchoalveolar Cell Lung Cancer.

StatusTrialSponsorPhase
UnknownThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor
NCT03896958
SpeciCare
CompletedRadiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell
NCT01958372
Barbara Ann Karmanos Cancer InstitutePhase 1
CompletedDocetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage
NCT01557959
Wake Forest University Health SciencesPhase 2
CompletedS0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell L
NCT00368992
National Cancer Institute (NCI)Phase 2
TerminatedBevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Adv
NCT00369551
National Cancer Institute (NCI)Phase 1
CompletedBortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer
NCT00118144
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Remov
NCT00049543
National Cancer Institute (NCI)Phase 3
CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurr
NCT00021060
National Cancer Institute (NCI)Phase 2 / Phase 3
TerminatedErlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III N
NCT00042835
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell
NCT00040794
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00029003
National Cancer Institute (NCI)Phase 2
CompletedCombination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III N
NCT00020709
National Cancer Institute (NCI)Phase 3
CompletedSurgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
NCT00002852
National Cancer Institute (NCI)Phase 3